Rockwell Medical Inc【RMTI】株式ニュース

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

Form 3 - Initial statement of beneficial ownership of securities

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Rockwell Medical Enters into a Multi-Year Product Purchase Agreement with the World's Leading Provider of Dialysis Products and Services

Partnership is expected to generate upwards of $10 million in net sales for the Company in 2025, with incremental price increases each subsequent...

Form 8-K - Current report

Rockwell Medical Promotes Jesse Neri to Chief Financial Officer

Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures...

Rockwell Medical Partners with HydroCare to Distribute and Install its Dry Acid Concentrate Mix System

Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a...

Rockwell Medical Expands Distribution in the Philippines

Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a...

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form 8-K - Current report

Form 424B5 - Prospectus [Rule 424(b)(5)]

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Rockwell Medical Reports Third Quarter 2024 Earnings, Generates Profitability on a Cash Flow and Adjusted EBITDA Basis for the Second Consecutive Quarter

Reports net product sales of $28.3 million for the third quarter of 2024, an increase of 31% over net product sales for the same period in 2023...

Rockwell Medical Announces Date Change for Third Quarter 2024 Earnings Conference Call and Webcast

Due to the U.S. Securities and Exchange Commission (SEC) and its Electronic Data Gathering, Analysis, and Retrieval (EDGAR) system being closed...

glenn1919 1月前

RMTI........................................https://stockcharts.com/h-sc/ui?s=RMTI&p=W&b=5&g=0&id=p86431144783

👍️0

glenn1919 3月前

RMTI.......................................https://stockcharts.com/h-sc/ui?s=RMTI&p=W&b=5&g=0&id=p86431144783

👍️0

glenn1919 4月前

RMTI.......................................https://stockcharts.com/h-sc/ui?s=RMTI&p=W&b=5&g=0&id=p86431144783

👍️0

glenn1919 5月前

RMTI..................................https://stockcharts.com/h-sc/ui?s=RMTI&p=W&b=5&g=0&id=p86431144783

👍️0

glenn1919 7月前

RMTI.............................https://stockcharts.com/h-sc/ui?s=RMTI&p=W&b=5&g=0&id=p86431144783

👍️0

glenn1919 9月前

RMTI..........................https://stockcharts.com/h-sc/ui?s=RMTI&p=W&b=5&g=0&id=p86431144783

👍️0

glenn1919 9月前

RMTI............................................https://stockcharts.com/h-sc/ui?s=RMTI&p=W&b=5&g=0&id=p86431144783

👍️0

triannual 10月前

Price targets are as low as $5. I'm in @ $1.22. The quarterly numbers have gotten better. I guess we will know on March 21st.Good luck

👍️ 1

4Godnwv 11月前

This thing has not been healthy in a while. I lost money on it last year, not sure why I’m even looking at it again. It took another major hit when they lowered guidance in January. The chart looks interesting, but charts don’t run on smoke and mirrors, they need material events to cause them to change directions. Watching - 4God

👍️0

triannual 11月前

Press Release: Rockwell Medical to Release Fourth Quarter and Full-Year 2023 Results on Thursday, March 21, 2024.
The numbers better be really good. If not it's lights out. They will end up on the OTC. GLTA

Recent news has stopped the bleeding. Expect Q3 numbers to lift the ppps here.

👍️0

4Godnwv 1年前

This thing got taken to the chopping block, but HC Wainwright may have pulled its bacon out of the fire.

👍️0

willlbone 1年前

Seems like they might dump 10 million shares at $1.39.

👍️0

Triple nickle 2年前

They beat estimates by almost double
Impressive outcome

👍️0

Jayzp 2年前

rmti vs ther

Ther can be big,with good news

https://www.prnewswire.com/news-releases/theralink-acquires-exclusive-landmark-immunotherapy-patent-including-biomarker-from-vanderbilt-university-301787847.html

$RMTI: Shes havng a nice day today.... now $1.30

Nice run up there on the daily chart

GO $RMTI

👍️0

GTF 2年前

New ceo trying to get back to basics...get the biz profitable without relying on Triferic.

👍️0

duderaja 3年前

Correct me if I'm wrong, but after the r/s the price should be 2.37 and it's 2.02 in pre-market which means it has dropped .35 in pre-market.

👍️0

Triple nickle 3年前

Premarket looks promising

$RMTI is scheduled to present at Aegis Virtual Conference, on Wednesday, February 23rd at 1:30 - 2:00 PM ET.
https://ih.advfn.com/stock-market/NASDAQ/rockwell-medical-RMTI/stock-news/87292951/rockwell-medical-inc-to-present-at-aegis-virtual

👍️0

instock58 3年前

RMTI NEWS " Rockwell Medical Announces Regulatory Approval of Triferic® Dialysate in South Korea
https://finance.yahoo.com/news/rockwell-medical-announces-regulatory-approval-141500983.html

UP 1% and starting to rise...News just our 25 mins ago...
Heavy Volume Picking up ...becoming heavier..

https://finance.yahoo.com/quote/RMTI?p=RMTI

Finviz
https://finviz.com/quote.ashx?t=RMTI

TradingView Buy Rated
https://www.tradingview.com/symbols/NASDAQ-RMTI/

$RMTI

👍️0

JetBlueJason 3年前

Agreed....
Needs some news to sustain it.

Murocman

👍️0

murocman 3年前

Needs some news to sustain it.

Murocman

👍️0

JetBlueJason 3年前

Moving North for sure $$$$$$
$RMTI

👍️0

TSCTOlson 3年前

$RMTI will have huge breakout from here, I think

👍️0

CarlCarlMcB 3年前

We be going North $$$$$:) air !!!!

👍️0

Bigbruin 3年前

Good morning from miami fla
Why is this moving up anyone ?

👍️0

CarlCarlMcB 3年前

Merry Christmas $$$$$$$:)

👍️0

TheFinalCD 3年前

https://finance.yahoo.com/news/rockwell-medical-study-demonstrates-no-210100032.html

https://ih.advfn.com/stock-market/NASDAQ/rockwell-medical-RMTI/stock-news/86578594/rockwell-medical-study-demonstrates-no-drug-drug-i

👍️0

BlazingStocks 3年前

A live webcast of the call will be available under "Events & Presentations" in the Investor section of the Company's website, https://ir.rockwellmed.com/. An archived webcast will be available on the Company's website approximately two hours after the event and will be available for 30 days.

To submit questions in advance, please email your questions to invest@rockwellmed.com.

$RMTI

👍️0

budfoxfun 3年前

$RMTI Rockwell Medical, Inc. to Report Second Quarter 2021 Financial and Operating Results on August 16, 2021 https://finance.yahoo.com/news/rockwell-medical-inc-report-second-110000902.html?soc_src=social-sh&soc_trk=tw&tsrc=twtr via @Yahoo

👍️0

BlazingStocks 3年前

$RMTI News July 29, 2021

Rockwell Medical, Inc. to Report Second Quarter 2021 Financial and Operating Results on August 16, 2021
https://finance.yahoo.com/news/rockwell-medical-inc-report-second-110000902.html

👍️0

budfoxfun 3年前

Green heading into the close!

RMTI

👍️0

BlazingStocks 3年前

$RMTI trading at approximately 30% of its 10-day average volume...but it's trading green.

👍️0

BlazingStocks 3年前

$RMTI will be able to tap into a largely under serviced patient pool...

👍️0

budfoxfun 3年前

$RMTI announced that it has submitted a pre-IND (Investigational New Drug) meeting request with the U.S. Food and Drug Administration (FDA) in support of its proposed Phase 2 clinical trial of Ferric Pyrophosphate Citrate (FPC), designed for the treatment of iron deficiency anemia and maintenance of hemoglobin in patients receiving infusion therapy in the home setting.

Home infusion represents a large and rapidly growing segment of healthcare. Many patient groups requiring home infusion therapies suffer from chronic diseases that are associated with a high incidence of iron deficiency and anemia. For example, it is estimated that 40%-55% of all home parenteral nutrition patients are iron deficient. Current treatment patterns can be inadequate for patients on home infusion therapy with iron deficiency anemia, causing them to suffer extreme fatigue and can result in serious health risks, such as, poor immune function and heart failure.

👍️0

BlazingStocks 3年前

PRODUCING AND DELIVERING HEMODIALYSIS CONCENTRATES AND ANCILLARY PRODUCTS TO DIALYSIS PROVIDERS

Rockwell Medical, $RMTI, is an innovative leader in producing and delivering hemodialysis concentrates (solutions and powders) along with related ancillary products to dialysis providers located throughout the U.S. and abroad.

Rockwell Medical is dedicated to providing the hemodialysis community with the highest quality products supported by the most reliable delivery service in the industry. Rockwell has multiple manufacturing locations throughout the United States to ensure fast and efficient delivery of our products. The company adheres to Good Manufacturing Practices (GMPs) and to the Association for Advancement of Medical Instrumentation (AAMI) standards in our manufacturing, ensuring a high-quality hemodialysate known throughout the industry for safety and excellence.

Our customer service department is dedicated to the fundamental principle that our customers are the most important part of our business. Our representatives strive to provide the highest level of courtesy and efficiency to our customers. Rockwell Medical is an independent supplier that does not own or operate dialysis clinics. Our focus is on providing customers with quality dialysis products.

https://www.rockwellmed.com/hemodialysis-concentrates/supporting-dialysis-providers/

👍️0

budfoxfun 3年前

$RMTI Rockwell Medical is a commercial-stage biopharmaceutical company developing and commercializing its next-generation parenteral iron technology platform, Ferric Pyrophosphate Citrate (FPC), which has the potential to lead transformative treatments for iron deficiency in multiple disease states, reduce healthcare costs and improve patients’ lives.

The Company has two FDA-approved therapies indicated for patients undergoing hemodialysis, which are the first two products developed from the FPC platform. The Company is developing FPC for the treatment of iron deficiency in patients outside of dialysis, who are receiving intravenous medications in the home infusion setting, a large and rapidly growing segment of healthcare, and where these patients suffer from chronic diseases associated with high incidence of iron deficiency and anemia.

In addition, Rockwell Medical is one of two major suppliers of life-saving hemodialysis concentrate products to kidney dialysis clinics in the United States. For more information, visit www.RockwellMed.com.

👍️0

BlazingStocks 3年前

Once we see updates from the FDA on this, $RMTI will see a great run...

👍️0

budfoxfun 3年前

“This is an important step for Rockwell Medical and home infusion patients as we believe that FPC is uniquely suited to address this important unmet clinical need,” said Russell Ellison, M.D., President and Chief Executive Officer of Rockwell Medical. “We expect to finalize our Phase 2 clinical study design and protocol with the advice and guidance of the FDA.”

RMTI

👍️0

BlazingStocks 3年前

I found this page of the website interesting and informative, to help me understand why this technology is so special.

https://www.rockwellmed.com/our-technology/technology-platform/

PLATFORM TECHNOLOGY TO MANAGE IRON IN A NEW WAY
Ferric pyrophosphate citrate (FPC) is a novel complex iron salt, developed to replace iron losses in patients with anemia in an entirely new way. This unique and differentiated molecule consists of an iron atom complexed to one pyrophosphate and two citrate anions. This formulation has been shown to allow for rapid donation of iron to transferrin, protein in the blood that binds to iron and transports it through the body, including to the bone marrow. This mechanism uses the body’s own means to transport iron safely to tissues that need iron (i.e. red blood cells and muscle).

👍️0

budfoxfun 3年前

$RMTI a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management and improving outcomes for patients around the world, today announced that it has submitted a pre-IND (Investigational New Drug) meeting request with the U.S. Food and Drug Administration (FDA) in support of its proposed Phase 2 clinical trial of Ferric Pyrophosphate Citrate (FPC), designed for the treatment of iron deficiency anemia and maintenance of hemoglobin in patients receiving infusion therapy in the home setting.

Home infusion represents a large and rapidly growing segment of healthcare. Many patient groups requiring home infusion therapies suffer from chronic diseases that are associated with a high incidence of iron deficiency and anemia. For example, it is estimated that 40%-55% of all home parenteral nutrition patients are iron deficient. Current treatment patterns can be inadequate for patients on home infusion therapy with iron deficiency anemia, causing them to suffer extreme fatigue and can result in serious health risks, such as, poor immune function and heart failure.

👍️0

BlazingStocks 3年前

Agreed, the $RTMI volume has decreased but the price action has been steady.

👍️0

budfoxfun 3年前

Nice support at these levels!

RMTI

👍️0

BlazingStocks 3年前

It's an interesting new technology...$RMTI

In addition, FPC iron is delivered regardless of other underlying conditions which might otherwise block the release of iron. Some of the challenges of managing iron in sick patients, including inflammation, hepcidin block, and functional iron deficiency, can be overcome with FPC due to its ability to provide bioavailable iron.

FPC is highly soluble in water and, therefore, can be formulated for parenteral administration either by the dialysis solution or intravenously. As a result, this novel approach to iron management has the potential for application in the treatment of anemia in many disease states.

👍️0

ProfitScout 3年前

The RMTI approach to anemia treatment is a clear advancement and holds great promise for improving the lives of millions of people who suffer from this problem around the world.

From the company website:

PLATFORM TECHNOLOGY TO MANAGE IRON IN A NEW WAY

Ferric pyrophosphate citrate (FPC) is a novel complex iron salt, developed to replace iron losses in patients with anemia in an entirely new way. This unique and differentiated molecule consists of an iron atom complexed to one pyrophosphate and two citrate anions. This formulation has been shown to allow for rapid donation of iron to transferrin, protein in the blood that binds to iron and transports it through the body, including to the bone marrow. This mechanism uses the body’s own means to transport iron safely to tissues that need iron (i.e. red blood cells and muscle).

Read more here:
https://www.rockwellmed.com/our-technology/technology-platform/

👍️0

BlazingStocks 3年前

$RMTI volume right around 20% of its 10-day average volume but trading GREEN!

👍️0

市場データ

ニュース

投資ツール

市場

発見

Hot Features

Follow Feed

ライブオプションフロー

モニター